Testicular Cancer

A Prototypic Tumor of Young Adults

Brandon Hayes-Lattin, Craig R. Nichols

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Testicular cancer is the most common solid tumor among males in the 20- to 39-year age range. Moreover, testicular cancer has unique biological associations, clinical features, and psychosocial impacts that establish this tumor as a prototypic malignancy of young adults. The biology of testicular germ cell tumors after puberty is distinctive. Epidemiologic patterns of testicular cancer suggest etiologic factors that may be congenital, racial, and geographic. The clinical management of a cancer common among young adults, but rare among adults in general, requires expertise so as not to jeopardize the high rates of survivorship associated with modern therapy. The concurrent but separate development of staging, prognostic systems, and treatment recommendations between the fields of pediatric and adult oncology highlights the need for increased integration and cooperation across these subspecialties. The high rate of survival, combined with the need for long-term monitoring for relapse or late effects, demonstrates the challenge of delivering longitudinal care in this mobile and active young adult population.

Original languageEnglish (US)
Pages (from-to)432-438
Number of pages7
JournalSeminars in Oncology
Volume36
Issue number5
DOIs
StatePublished - Oct 2009

Fingerprint

Testicular Neoplasms
Young Adult
Neoplasms
Puberty
Pediatrics
Recurrence
Therapeutics
Population

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Testicular Cancer : A Prototypic Tumor of Young Adults. / Hayes-Lattin, Brandon; Nichols, Craig R.

In: Seminars in Oncology, Vol. 36, No. 5, 10.2009, p. 432-438.

Research output: Contribution to journalArticle

Hayes-Lattin, Brandon ; Nichols, Craig R. / Testicular Cancer : A Prototypic Tumor of Young Adults. In: Seminars in Oncology. 2009 ; Vol. 36, No. 5. pp. 432-438.
@article{c435f9ce14df411e984f53b7d1362e8d,
title = "Testicular Cancer: A Prototypic Tumor of Young Adults",
abstract = "Testicular cancer is the most common solid tumor among males in the 20- to 39-year age range. Moreover, testicular cancer has unique biological associations, clinical features, and psychosocial impacts that establish this tumor as a prototypic malignancy of young adults. The biology of testicular germ cell tumors after puberty is distinctive. Epidemiologic patterns of testicular cancer suggest etiologic factors that may be congenital, racial, and geographic. The clinical management of a cancer common among young adults, but rare among adults in general, requires expertise so as not to jeopardize the high rates of survivorship associated with modern therapy. The concurrent but separate development of staging, prognostic systems, and treatment recommendations between the fields of pediatric and adult oncology highlights the need for increased integration and cooperation across these subspecialties. The high rate of survival, combined with the need for long-term monitoring for relapse or late effects, demonstrates the challenge of delivering longitudinal care in this mobile and active young adult population.",
author = "Brandon Hayes-Lattin and Nichols, {Craig R.}",
year = "2009",
month = "10",
doi = "10.1053/j.seminoncol.2009.07.006",
language = "English (US)",
volume = "36",
pages = "432--438",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Testicular Cancer

T2 - A Prototypic Tumor of Young Adults

AU - Hayes-Lattin, Brandon

AU - Nichols, Craig R.

PY - 2009/10

Y1 - 2009/10

N2 - Testicular cancer is the most common solid tumor among males in the 20- to 39-year age range. Moreover, testicular cancer has unique biological associations, clinical features, and psychosocial impacts that establish this tumor as a prototypic malignancy of young adults. The biology of testicular germ cell tumors after puberty is distinctive. Epidemiologic patterns of testicular cancer suggest etiologic factors that may be congenital, racial, and geographic. The clinical management of a cancer common among young adults, but rare among adults in general, requires expertise so as not to jeopardize the high rates of survivorship associated with modern therapy. The concurrent but separate development of staging, prognostic systems, and treatment recommendations between the fields of pediatric and adult oncology highlights the need for increased integration and cooperation across these subspecialties. The high rate of survival, combined with the need for long-term monitoring for relapse or late effects, demonstrates the challenge of delivering longitudinal care in this mobile and active young adult population.

AB - Testicular cancer is the most common solid tumor among males in the 20- to 39-year age range. Moreover, testicular cancer has unique biological associations, clinical features, and psychosocial impacts that establish this tumor as a prototypic malignancy of young adults. The biology of testicular germ cell tumors after puberty is distinctive. Epidemiologic patterns of testicular cancer suggest etiologic factors that may be congenital, racial, and geographic. The clinical management of a cancer common among young adults, but rare among adults in general, requires expertise so as not to jeopardize the high rates of survivorship associated with modern therapy. The concurrent but separate development of staging, prognostic systems, and treatment recommendations between the fields of pediatric and adult oncology highlights the need for increased integration and cooperation across these subspecialties. The high rate of survival, combined with the need for long-term monitoring for relapse or late effects, demonstrates the challenge of delivering longitudinal care in this mobile and active young adult population.

UR - http://www.scopus.com/inward/record.url?scp=70349759471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349759471&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2009.07.006

DO - 10.1053/j.seminoncol.2009.07.006

M3 - Article

VL - 36

SP - 432

EP - 438

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 5

ER -